Anti-C4d Antibody (FITC)

原厂品牌:BIOMEDICA

规格选择
货号规格目录价货期
BI-RC4D-FITC100 µl (125 tests) ¥4,6903~4周

产品详情

Circulating alloantibodies encounter the grafted endothelium as the first target. Living endothelial cells can rapidly eliminate bound antibodies from the cell surface by “capping”, “shedding” or “internalisation”. C4d is the degradation product of the activated complement factor C4, a component of the classical complement cascade, which is typically initiated by binding of antibodies to specific target molecules. Detection of C4d is regarded as an indirect sign, a “footprint” of an antibody response against the allograft. The majority of publications describe C4d as an important biomarker in kidney transplantation but also in heart, liver, and other transplants. Organ transplantation Kidney transplantation Liver transplantation Heart transplantation Lung transplantation

The Anti-C4d FITC antibody will identify human complement split product C4d. It is suggested to be a valuable marker for humoral rejection of transplants (kidney, heart, lung). The antibody is applicable for detection of cell- or solid-phase bound C4 and C4d split product by flow cytometry using FlowPRA® Class I and II screening test beads from One Lambda, Inc.

共 0 条

暂无评价